Comments on:

Trial lawyers helped FDA with rule opening generic drug firms to lawsuits

Back to the article » By |
Paul Bedard,Washington Secrets,Supreme Court,FDA,Pharmaceutical Industry
The association that represents America's trial lawyers played a special role in the Food and Drug Administration's process of developing a new rule that opens the door to suits against generic drug makers, a potential financial bonanza to lawyers -- and a $4 billion hit to consumers and the government. In a letter to a House committee, the FDA singled out the trial lawyers group, the American...